{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:26:11Z","timestamp":1778736371797,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1245\/s10434-023-14207-7","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:02:38Z","timestamp":1694610158000},"page":"7362-7370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network"],"prefix":"10.1245","volume":"30","author":[{"given":"Sean J.","family":"Judge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Ghalambor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Cavnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Lidsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan P.","family":"Merkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Dominguez-Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Karanicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skye C.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio G.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan C.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagen F.","family":"Kennecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas Groot","family":"Koerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam C.","family":"Yopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Petrowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devalingham","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"9","key":"14207_CR1","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1245\/s10434-013-3009-3","volume":"20","author":"JB Ammori","year":"2013","unstructured":"Ammori JB, Kemeny NE, Fong Y, et al. Conversion to complete resection and\/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ann Surg Oncol. 2013;20(9):2901\u20137. https:\/\/doi.org\/10.1245\/s10434-013-3009-3.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"14207_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jamcollsurg.2020.11.013","volume":"232","author":"R Anteby","year":"2021","unstructured":"Anteby R, Kemeny NE, Kingham PT, et al. Getting chemotherapy directly to the liver: the historical evolution of hepatic artery chemotherapy. J Am Coll Surg. 2021;232(3):332\u20138.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"14207_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","volume":"107","author":"N Kemeny","year":"1987","unstructured":"Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med. 1987;107(4):459\u201365. https:\/\/doi.org\/10.7326\/0003-4819-107-4-459.","journal-title":"Ann Intern Med"},{"issue":"11","key":"14207_CR4","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","volume":"7","author":"DC Hohn","year":"1989","unstructured":"Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989;7(11):1646\u201354. https:\/\/doi.org\/10.1200\/JCO.1989.7.11.1646.","journal-title":"J Clin Oncol"},{"issue":"7","key":"14207_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","volume":"10","author":"P Rougier","year":"1992","unstructured":"Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10(7):1112\u20138. https:\/\/doi.org\/10.1200\/JCO.1992.10.7.1112.","journal-title":"J Clin Oncol"},{"issue":"2","key":"14207_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"M Lorenz","year":"2000","unstructured":"Lorenz M, M\u00fcller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000;18(2):243\u2013243. https:\/\/doi.org\/10.1200\/JCO.2000.18.2.243.","journal-title":"J Clin Oncol"},{"issue":"2","key":"14207_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jso.20286","volume":"91","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Eid A, Stockman J, et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol. 2005;91(2):97\u2013101. https:\/\/doi.org\/10.1002\/jso.20286.","journal-title":"J Surg Oncol"},{"issue":"22","key":"14207_CR8","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1200\/JCO.2005.07.100","volume":"23","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005;23(22):4888\u201396. https:\/\/doi.org\/10.1200\/JCO.2005.07.100.","journal-title":"J Clin Oncol"},{"issue":"22","key":"14207_CR9","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","volume":"23","author":"M Ducreux","year":"2005","unstructured":"Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the Gastrointestinal Group of the F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005;23(22):4881\u20137. https:\/\/doi.org\/10.1200\/JCO.2005.05.120.","journal-title":"J Clin Oncol"},{"issue":"21","key":"14207_CR10","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","volume":"27","author":"NE Kemeny","year":"2009","unstructured":"Kemeny NE, Melendez FDH, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27(21):3465\u201371. https:\/\/doi.org\/10.1200\/JCO.2008.20.1301.","journal-title":"J Clin Oncol"},{"issue":"4","key":"14207_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/SLA.0b013e3181d35983","volume":"251","author":"D Go\u00e9r\u00e9","year":"2010","unstructured":"Go\u00e9r\u00e9 D, Deshaies I, de Baere T, et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg. 2010;251(4):686\u201391.","journal-title":"Ann Surg"},{"issue":"2","key":"14207_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","volume":"261","author":"MI D\u2019Angelica","year":"2015","unstructured":"D\u2019Angelica MI, Correa-Gallego C, Paty PB, et al. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Ann Surg. 2015;261(2):353\u201360. https:\/\/doi.org\/10.1097\/SLA.0000000000000614.","journal-title":"Ann Surg"},{"issue":"4","key":"14207_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jso.24898","volume":"117","author":"LM Pak","year":"2018","unstructured":"Pak LM, Kemeny NE, Capanu M, et al. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: long term results and curative potential. J Surg Oncol. 2018;117(4):634\u201343. https:\/\/doi.org\/10.1002\/jso.24898.","journal-title":"J Surg Oncol"},{"issue":"6","key":"14207_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/00000658-199812000-00006","volume":"228","author":"M Lorenz","year":"1998","unstructured":"Lorenz M, M\u00fcller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg. 1998;228(6):756\u201362. https:\/\/doi.org\/10.1097\/00000658-199812000-00006.","journal-title":"Ann Surg"},{"issue":"27","key":"14207_CR15","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","volume":"341","author":"N Kemeny","year":"1999","unstructured":"Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341(27):2039\u201348. https:\/\/doi.org\/10.1056\/NEJM199912303412702.","journal-title":"N Engl J Med"},{"issue":"6","key":"14207_CR16","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1200\/JCO.2002.20.6.1499","volume":"20","author":"MM Kemeny","year":"2002","unstructured":"Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy\u2014an intergroup study. J Clin Oncol. 2002;20(6):1499\u2013505. https:\/\/doi.org\/10.1200\/JCO.2002.20.6.1499.","journal-title":"J Clin Oncol"},{"issue":"7","key":"14207_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJM200502173520723","volume":"352","author":"NE Kemeny","year":"2005","unstructured":"Kemeny NE, Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med. 2005;352(7):734\u20135. https:\/\/doi.org\/10.1056\/NEJM200502173520723.","journal-title":"N Engl J Med"},{"issue":"6","key":"14207_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/SLA.0b013e31822f4f88","volume":"254","author":"MG House","year":"2011","unstructured":"House MG, Kemeny NE, G\u00f6nen M, et al. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Ann Surg. 2011;254(6):851\u20136.","journal-title":"Ann Surg"},{"issue":"17","key":"14207_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1200\/JCO.2016.71.8346","volume":"35","author":"B Groot Koerkamp","year":"2017","unstructured":"Groot Koerkamp B, Sadot E, Kemeny NE, et al. Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: a propensity score analysis. J Clin Oncol. 2017;35(17):1938\u201344. https:\/\/doi.org\/10.1200\/JCO.2016.71.8346.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14207_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","volume":"6","author":"A Cercek","year":"2020","unstructured":"Cercek A, Boerner T, Tan BR, et al. Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6(1):60\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3718.","journal-title":"JAMA Oncol"},{"issue":"2","key":"14207_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jso.23781","volume":"111","author":"LM Boehm","year":"2015","unstructured":"Boehm LM, Jayakrishnan TT, Miura JT, et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. J Surg Oncol. 2015;111(2):213\u201320. https:\/\/doi.org\/10.1002\/jso.23781.","journal-title":"J Surg Oncol"},{"issue":"1","key":"14207_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1245\/s10434-021-10279-5","volume":"29","author":"AJ Rossi","year":"2022","unstructured":"Rossi AJ, Khan TM, Luna AJ, Cercek A, Jarnagin WR, Hernandez JM. Hepatic Artery Infusion Pump (HAIP) therapy versus chemotherapy in the first-line setting for patients with unresectable intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2022;29(1):35\u20136. https:\/\/doi.org\/10.1245\/s10434-021-10279-5.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"14207_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2214\/ajr.181.5.1811327","volume":"181","author":"S Sumie","year":"2003","unstructured":"Sumie S, Yamashita F, Ando E, et al. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. Am J Roentgenol. 2003;181(5):1327\u201334. https:\/\/doi.org\/10.2214\/ajr.181.5.1811327.","journal-title":"Am J Roentgenol"},{"issue":"7","key":"14207_CR24","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/bjc.2013.542","volume":"109","author":"K Nouso","year":"2013","unstructured":"Nouso K, Miyahara K, Uchida D, et al. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan. Br J Cancer. 2013;109(7):1904\u20137. https:\/\/doi.org\/10.1038\/bjc.2013.542.","journal-title":"Br J Cancer"},{"issue":"7","key":"14207_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamaoncol.2019.0250","volume":"5","author":"M He","year":"2019","unstructured":"He M, Li Q, Zou R, et al. Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized clinical trial. JAMA Oncol. 2019;5(7):953\u201360. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0250.","journal-title":"JAMA Oncol"},{"issue":"12","key":"14207_CR26","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.hpb.2022.08.008","volume":"24","author":"M Cavnar","year":"2022","unstructured":"Cavnar M, Ghalambor T, Lidsky ME, et al. Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. HPB. 2022;24(12):2104\u201311. https:\/\/doi.org\/10.1016\/j.hpb.2022.08.008.","journal-title":"HPB"},{"issue":"3","key":"14207_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309.","journal-title":"Ann Surg"},{"issue":"1","key":"14207_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-019-5515-6","volume":"19","author":"FE Buisman","year":"2019","unstructured":"Buisman FE, Homs MYV, Gr\u00fcnhagen DJ, et al. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases\u2014the multicenter randomized controlled PUMP trial. BMC Cancer. 2019;19(1):327\u2013327. https:\/\/doi.org\/10.1186\/s12885-019-5515-6.","journal-title":"BMC Cancer"},{"key":"14207_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejca.2018.12.019","volume":"109","author":"DP Modest","year":"2019","unstructured":"Modest DP, Pant S, Sartore-Bianchi A. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019;109:70\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.019.","journal-title":"Eur J Cancer"},{"issue":"3","key":"14207_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.clcc.2014.06.001","volume":"13","author":"V Morris","year":"2014","unstructured":"Morris V, Overman MJ, Jiang ZQ, et al. Progression-free survival remains poor over sequential lines of systemic therapy in patients With BRAF-mutated colorectal cancer. Clin Colorectal Cancer. 2014;13(3):164\u201371. https:\/\/doi.org\/10.1016\/j.clcc.2014.06.001.","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"14207_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3816\/CCC.2009.n.038","volume":"8","author":"JH Slade","year":"2009","unstructured":"Slade JH, Alattar ML, Fogelman DR, et al. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer. 2009;8(4):225\u201330. https:\/\/doi.org\/10.3816\/CCC.2009.n.038.","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"14207_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/jso.24399","volume":"114","author":"A Cercek","year":"2016","unstructured":"Cercek A, Boucher TM, Gluskin JS, et al. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. J Surg Oncol. 2016;114(6):655\u201363. https:\/\/doi.org\/10.1002\/jso.24399.","journal-title":"J Surg Oncol"},{"issue":"14","key":"14207_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med"},{"issue":"8","key":"14207_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1(8):15. https:\/\/doi.org\/10.1056\/EVIDoa2200015.","journal-title":"NEJM Evid"},{"issue":"5","key":"14207_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.29824","volume":"122","author":"IT Konstantinidis","year":"2016","unstructured":"Konstantinidis IT, Koerkamp BG, Do RKG, et al. Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Cancer. 2016;122(5):758\u201365. https:\/\/doi.org\/10.1002\/cncr.29824.","journal-title":"Cancer"},{"issue":"9","key":"14207_CR36","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1245\/s10434-022-11439-x","volume":"29","author":"JJ Holster","year":"2022","unstructured":"Holster JJ, El Hassnaoui M, Franssen S, et al. Hepatic arterial infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2022;29(9):5528\u201338. https:\/\/doi.org\/10.1245\/s10434-022-11439-x.","journal-title":"Ann Surg Oncol"},{"issue":"9355","key":"14207_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(03)12388-4","volume":"361","author":"DJ Kerr","year":"2003","unstructured":"Kerr DJ, McArdle CS, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet. 2003;361(9355):368\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(03)12388-4.","journal-title":"Lancet"},{"issue":"5","key":"14207_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1023\/A:1011186708754","volume":"12","author":"W Kern","year":"2001","unstructured":"Kern W, Beckert B, Lang N, et al. Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol. 2001;12(5):599\u2013603. https:\/\/doi.org\/10.1023\/A:1011186708754.","journal-title":"Ann Oncol"},{"issue":"6","key":"14207_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","volume":"8","author":"AD Cohen","year":"2003","unstructured":"Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist. 2003;8(6):553\u201366. https:\/\/doi.org\/10.1634\/theoncologist.8-6-553.","journal-title":"Oncologist"},{"issue":"12","key":"14207_CR40","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1245\/s10434-022-12085-z","volume":"29","author":"RR Narayan","year":"2022","unstructured":"Narayan RR, Datta J, Goldman DA, et al. Genomic predictors of recurrence patterns after complete resection of colorectal liver metastases and adjuvant hepatic artery infusion chemotherapy. Ann Surg Oncol. 2022;29(12):7579\u201388. https:\/\/doi.org\/10.1245\/s10434-022-12085-z.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"14207_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/SLA.0000000000003248","volume":"272","author":"S Gholami","year":"2020","unstructured":"Gholami S, Kemeny NE, Boucher TM, et al. Adjuvant hepatic artery infusion chemotherapy is associated with improved survival regardless of KRAS mutation status in patients with resected colorectal liver metastases: a retrospective analysis of 674 patients. Ann Surg. 2020;272(2):352\u20136. https:\/\/doi.org\/10.1097\/SLA.0000000000003248.","journal-title":"Ann Surg"},{"issue":"2","key":"14207_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/SLA.0000000000004923","volume":"274","author":"NE Kemeny","year":"2021","unstructured":"Kemeny NE, Chou JF, Capanu M, et al. A randomized phase II trial of adjuvant hepatic arterial infusion and systemic therapy with or without panitumumab after hepatic resection of KRAS wild-type colorectal cancer. Ann Surg. 2021;274(2):248\u201354.","journal-title":"Ann Surg"},{"issue":"13","key":"14207_CR43","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1245\/s10434-020-08938-0","volume":"27","author":"BC Brajcich","year":"2020","unstructured":"Brajcich BC, Bentrem DJ, Yang AD, et al. Short-term risk of performing concurrent procedures with hepatic artery infusion pump placement. Ann Surg Oncol. 2020;27(13):5098\u2013106. https:\/\/doi.org\/10.1245\/s10434-020-08938-0.","journal-title":"Ann Surg Oncol"},{"key":"14207_CR44","volume-title":"A lifesaving pump for cancer patients is being phased out","author":"D Grady","year":"2018","unstructured":"Grady D, Kaplan S. A lifesaving pump for cancer patients is being phased out. New York Times; 2018."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14207-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14207-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14207-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:04:45Z","timestamp":1696917885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14207-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["14207"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14207-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}